Guidelines for the administration of biological therapy in patients with inflammatory bowel diseases: fourth, updated edition
dc.contributor.author | Nedbalová Lenka | cs |
dc.date.accessioned | 2020-06-08T09:49:19Z | |
dc.date.available | 04-30-2020 | en |
dc.date.available | 2020-06-08T09:49:19Z | |
dc.date.issued | 2019 | cs |
dc.date.updated | 05-36-2020 | en |
dc.format.extent | 14 | cs |
dc.identifier.issn | 1804-7874 | cs |
dc.identifier.uri | https://dspace.tul.cz/handle/15240/156566 | |
dc.language.iso | cze | cs |
dc.publisher | AmbitMedia, a.s. | cs |
dc.publisher.city | Praha | cs |
dc.relation.ispartof | Gastroenterology and Hepatology | en |
dc.relation.ispartofseries | 0 | cs |
dc.subject | Crohn`s disease | cs |
dc.subject | ulcerative colitis | cs |
dc.subject | infliximab | cs |
dc.subject | adalimumab | cs |
dc.subject | ustekinumab | cs |
dc.subject | vedolizumab | cs |
dc.subject | golimumab | cs |
dc.subject | therapy | cs |
dc.title | Guidelines for the administration of biological therapy in patients with inflammatory bowel diseases: fourth, updated edition | en |
dc.title | Doporučení pro podávání biologické léčby pacientům s idiopatickými střevními záněty:čtvrté, aktualizované vydání | cs |
local.citation.epage | 11-24 | cs |
local.citation.spage | 11-24 | cs |
local.identifier.publikace | 7346 | |
local.relation.issue | 1 | cs |